Compare Abeona Therapeutics Inc (ABEO) vs Aurora Cannabis Inc (ACB) Price & Performance

Abeona Therapeutics IncTrade

Aurora Cannabis IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Aurora Cannabis Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while Aurora Cannabis Inc trades at $3.59 (market cap $223.59M). The key difference: Abeona Therapeutics Inc is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

	ABEO	ACB
Market Cap	$421.19M	$223.59M
Sector	Health	Health
52-Week High	$7.45	$6.23
52-Week Low	$4.17	$2.58
Enterprise Value	$276.10M	$168.09M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

ACB

Aurora Cannabis reviews unsolicited $4/share takeover bid from Curaleaf, no decision yet.PRNewsWire · 22 hours agoNeutral Curaleaf launches hostile bid to acquire Aurora Cannabis at $4 per share, offering shares plus cash.Proactive Investors · 22 hours agoBullish Curaleaf offers to buy Aurora Cannabis with a 45% premium, aiming to create a leading global cannabis platform.PRNewsWire · 1 day agoBullish View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.